RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment
Van Dam Peter André   Verhoeven Yannick   Trinh Xuan Bich   Wouters An   Lardon Filip   Prenen Hans   Smits Evelien   Baldewijns Marcella   Lammens Martin  
Critical reviews in oncology, hematology - ISSN 1040-8428-133 (2019) p. 85-91
Citatielink

Overcoming intrinsic and acquired cetuximab resistance in RAS wild-type colorectal cancer : an in vitro study on the expression of HER receptors and the potential of afatinib
De Pauw Ines   Lardon Filip   Van den Bossche Jolien   Baysal Hasan   Pauwels Patrick   Peeters Marc   Vermorken Jan Baptist   Wouters An  
Cancers - ISSN 2072-6694-11:1 (2019)
Citatielink

RANK-RANKL signaling in cancer of the uterine cervix : a review
Van Dam Peter André   Verhoeven Yannick   Jacobs Julie   Wouters An   Tjalma Wiebren   Lardon Filip   van den Wyngaert Tim   Dewulf Jonatan   Smits Evelien   Colpaert Cecile   Prenen Hans   Peeters Marc   Lammens Martin   Trinh Xuan Bich  
International journal of molecular sciences - ISSN 1661-6596-20:9 (2019)
Citatielink

Circulating cell-free DNA and RNA analysis as liquid biopsy : optimal centrifugation protocol
Sorber Laure   Zwaenepoel Karen   Jacobs Julie   De Winne Koen   Goethals Sofie   Reclusa Pablo   Van Casteren Kaat   Augustus Elien   Lardon Filip   Roeyen Geert   Peeters Marc   van Meerbeeck Jan   Rolfo Christian   Pauwels Patrick  
Cancers - ISSN 2072-6694-11:4 (2019)
Citatielink

Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line
Van Der Steen Nele   Leonetti Alessandro   Keller Kaylee   Dekker Henk   Funel Niccola   Lardon Filip   Ruijtenbeek Rob   Tiseo Marcello   Rolfo Christian   Pauwels Patrick   Peters Godefridus J.   Giovannetti Elisa  
Biochemical pharmacology - ISSN 0006-2952-166 (2019) p. 128-138
Citatielink